-
1
-
-
0000143003
-
Folic acid
-
Shils ME, Olson JA, Shike M, Ross AH eds, ed 9. London, Lippincott Williams & Wilkins
-
Herbert V: Folic acid; in Shils ME, Olson JA, Shike M, Ross AH (eds): Modern Nutrition in Health and Disease, ed 9. London, Lippincott Williams & Wilkins, 1999, pp 433-446.
-
(1999)
Modern Nutrition in Health and Disease
, pp. 433-446
-
-
Herbert, V.1
-
2
-
-
0005806609
-
Nutrition
-
Cohen WR, Cherry SH, Merkatz IR eds, ed 5. London, Lippincott Williams & Wilkins
-
Worthington-Roberts BS: Nutrition; in Cohen WR, Cherry SH, Merkatz IR (eds): Cherry and Merkatz's Complications of Pregnancy, ed 5. London, Lippincott Williams & Wilkins, 1999, pp 17-49.
-
(1999)
Cherry and Merkatz's Complications of Pregnancy
, pp. 17-49
-
-
Worthington-Roberts, B.S.1
-
3
-
-
0033808685
-
Folic acid: Nutritional biochemistry, molecular biology, and role in disease processes
-
Lucock M: Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Gen Metab 2000;71:121-138.
-
(2000)
Mol Gen Metab
, vol.71
, pp. 121-138
-
-
Lucock, M.1
-
4
-
-
0038653312
-
Pregnancy and lactation: Physiological adjustments, nutritional requirements and the role of dietary supplements
-
Picciano MF: Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr 2003;133:1997S-2002S.
-
(2003)
J Nutr
, vol.133
-
-
Picciano, M.F.1
-
5
-
-
33745143253
-
Comparison of folate uptake characteristics by human placental choriocarcinoma cells at acidic and physiological pH
-
Keating E, Lemos C, Azevedo I, Martel F: Comparison of folate uptake characteristics by human placental choriocarcinoma cells at acidic and physiological pH. Can J Physiol Pharmacol 2006;84:247-255.
-
(2006)
Can J Physiol Pharmacol
, vol.84
, pp. 247-255
-
-
Keating, E.1
Lemos, C.2
Azevedo, I.3
Martel, F.4
-
6
-
-
47749085946
-
-
submitted
-
Keating E, Gonçalves P, Campos I, Costa F, Azevedo I, Martel F: Placental folic acid uptake: interference by pharmacotherapy, drugs of abuse and pathological conditions (submitted).
-
Placental folic acid uptake: Interference by pharmacotherapy, drugs of abuse and pathological conditions
-
-
Keating, E.1
Gonçalves, P.2
Campos, I.3
Costa, F.4
Azevedo, I.5
Martel, F.6
-
7
-
-
34748874939
-
Placental vitamin B 9 uptake: Characterization in human isolated cytotrophoblasts
-
Keating E, Lemos C, Costa F, Campos I, Azevedo I, Martel F: Placental vitamin B 9 uptake: characterization in human isolated cytotrophoblasts. Placenta 2005;26:A48.
-
(2005)
Placenta
, vol.26
-
-
Keating, E.1
Lemos, C.2
Costa, F.3
Campos, I.4
Azevedo, I.5
Martel, F.6
-
8
-
-
0041305877
-
Membrane transport of folates
-
Matherly LH, Goldman DI: Membrane transport of folates. Vitam Horm 2003;66:403-456.
-
(2003)
Vitam Horm
, vol.66
, pp. 403-456
-
-
Matherly, L.H.1
Goldman, D.I.2
-
9
-
-
0032807982
-
Carrier-mediated membrane transport of folates in mammalian cells
-
Sirotnak FM, Tolner B: Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 1999;19:91-122.
-
(1999)
Annu Rev Nutr
, vol.19
, pp. 91-122
-
-
Sirotnak, F.M.1
Tolner, B.2
-
10
-
-
33751244559
-
Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption
-
Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, Goldman ID: Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006;127:917-928.
-
(2006)
Cell
, vol.127
, pp. 917-928
-
-
Qiu, A.1
Jansen, M.2
Sakaris, A.3
Min, S.H.4
Chattopadhyay, S.5
Tsai, E.6
Sandoval, C.7
Zhao, R.8
Akabas, M.H.9
Goldman, I.D.10
-
11
-
-
41549104123
-
Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model
-
Inoue K, Nakai Y, Ueda S, Kamigaso S, Ohta KY, Hatakeyama M, Hayashi Y, Otagiri M, Yuasa H: Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. Am J Physiol Gastrointest Liver Physiol 2008;294:G660-G668.
-
(2008)
Am J Physiol Gastrointest Liver Physiol
, vol.294
-
-
Inoue, K.1
Nakai, Y.2
Ueda, S.3
Kamigaso, S.4
Ohta, K.Y.5
Hatakeyama, M.6
Hayashi, Y.7
Otagiri, M.8
Yuasa, H.9
-
12
-
-
0037308791
-
Pregnancy-related substance abuse in the United States during 1996-1998
-
Ebrahim S, Gfroerer J: Pregnancy-related substance abuse in the United States during 1996-1998. Obstet Gynecol 2003;101:374-379.
-
(2003)
Obstet Gynecol
, vol.101
, pp. 374-379
-
-
Ebrahim, S.1
Gfroerer, J.2
-
13
-
-
0036851836
-
Alcohol, tobacco and marijuana use among pregnant teenagers:6-year follow-up of offspring growth effects
-
Cornelius M, Goldschmidt L, Day N, Larkby C: Alcohol, tobacco and marijuana use among pregnant teenagers:6-year follow-up of offspring growth effects. Neurotoxicol Teratol 2002;24:703-710.
-
(2002)
Neurotoxicol Teratol
, vol.24
, pp. 703-710
-
-
Cornelius, M.1
Goldschmidt, L.2
Day, N.3
Larkby, C.4
-
14
-
-
0036362325
-
ALSPAC study team: Maternal use of cannabis and pregnancy outcome
-
Fergusson D, Horwood L, Northstone K; ALSPAC study team: Maternal use of cannabis and pregnancy outcome. Br J Obstet Gynaecol 2002;109:21-27.
-
(2002)
Br J Obstet Gynaecol
, vol.109
, pp. 21-27
-
-
Fergusson, D.1
Horwood, L.2
Northstone, K.3
-
15
-
-
4644331847
-
Cannabinoid physiology and pharmacology: 30 years of progress
-
Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ: Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004;47:345-358.
-
(2004)
Neuropharmacology
, vol.47
, pp. 345-358
-
-
Howlett, A.C.1
Breivogel, C.S.2
Childers, S.R.3
Deadwyler, S.A.4
Hampson, R.E.5
Porrino, L.J.6
-
16
-
-
18444376760
-
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
-
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG: International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202.
-
(2002)
Pharmacol Rev
, vol.54
, pp. 161-202
-
-
Howlett, A.C.1
Barth, F.2
Bonner, T.I.3
Cabral, G.4
Casellas, P.5
Devane, W.A.6
Felder, C.C.7
Herkenham, M.8
Mackie, K.9
Martin, B.R.10
Mechoulam, R.11
Pertwee, R.G.12
-
17
-
-
0032857273
-
Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta
-
Kenney SP, Kekuda R, Prasad PD, Leibach FH, Devoe LD, Ganapathy V: Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am J Obstet Gynecol 1999;181:491-497.
-
(1999)
Am J Obstet Gynecol
, vol.181
, pp. 491-497
-
-
Kenney, S.P.1
Kekuda, R.2
Prasad, P.D.3
Leibach, F.H.4
Devoe, L.D.5
Ganapathy, V.6
-
18
-
-
34247640716
-
Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes
-
Shivachar AC: Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes. Biochem Pharmacol 2007;73:2004-2011.
-
(2007)
Biochem Pharmacol
, vol.73
, pp. 2004-2011
-
-
Shivachar, A.C.1
-
19
-
-
34047181576
-
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum
-
Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Giuffrida A: CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem 2007;101:389-396.
-
(2007)
J Neurochem
, vol.101
, pp. 389-396
-
-
Price, D.A.1
Owens, W.A.2
Gould, G.G.3
Frazer, A.4
Roberts, J.L.5
Daws, L.C.6
Giuffrida, A.7
-
20
-
-
33745620507
-
Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells
-
Nieri P, Romiti N, Adinolfi B, Chicca A, Massarelli I, Chieli E: Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells. Br J Pharmacol 2006;148:682-687.
-
(2006)
Br J Pharmacol
, vol.148
, pp. 682-687
-
-
Nieri, P.1
Romiti, N.2
Adinolfi, B.3
Chicca, A.4
Massarelli, I.5
Chieli, E.6
-
21
-
-
33646734889
-
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
-
Carrier EJ, Auchampach JA, Hillard CJ: Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 2006;103:7895-7900.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 7895-7900
-
-
Carrier, E.J.1
Auchampach, J.A.2
Hillard, C.J.3
-
22
-
-
46449122347
-
Effect of pathological conditions, pharmacotherapy and drugs of abuse upon folic acid placental uptake
-
Keating E, Gonçalves P, Campos I, Costa F, Azevedo I, Martel F: Effect of pathological conditions, pharmacotherapy and drugs of abuse upon folic acid placental uptake. FASEB J 2007;21:A602.
-
(2007)
FASEB J
, vol.21
-
-
Keating, E.1
Gonçalves, P.2
Campos, I.3
Costa, F.4
Azevedo, I.5
Martel, F.6
-
23
-
-
37549048592
-
Acute and chronic effects of some dietary bioactive compounds on folic acid uptake and on the expression of folic acid transporters by the human trophoblast cell line BeWo
-
Keating E, Lemos C, Gonçalves P, Azevedo I, Martel F: Acute and chronic effects of some dietary bioactive compounds on folic acid uptake and on the expression of folic acid transporters by the human trophoblast cell line BeWo. J Nutr Biochem 2008;19:91-100.
-
(2008)
J Nutr Biochem
, vol.19
, pp. 91-100
-
-
Keating, E.1
Lemos, C.2
Gonçalves, P.3
Azevedo, I.4
Martel, F.5
-
24
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
25
-
-
0017184389
-
A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford MM: A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
26
-
-
0027078685
-
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
-
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-1949.
-
(1992)
Science
, vol.258
, pp. 1946-1949
-
-
Devane, W.A.1
Hanus, L.2
Breuer, A.3
Pertwee, R.G.4
Stevenson, L.A.5
Griffin, G.6
Gibson, D.7
Mandelbaum, A.8
Etinger, A.9
Mechoulam, R.10
-
27
-
-
0032802188
-
Pharmacology of cannabinoid receptor ligands
-
Pertwee RG: Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999;6:635-664.
-
(1999)
Curr Med Chem
, vol.6
, pp. 635-664
-
-
Pertwee, R.G.1
-
29
-
-
0031981037
-
Comparative receptor binding analyses of cannabinoid agonists and antagonists
-
Thomas BF, Gilliam AF, Burch DF, Roche MJ, Seltzman HH: Comparative receptor binding analyses of cannabinoid agonists and antagonists. J Pharmacol Exp Ther 1998;285:285-292.
-
(1998)
J Pharmacol Exp Ther
, vol.285
, pp. 285-292
-
-
Thomas, B.F.1
Gilliam, A.F.2
Burch, D.F.3
Roche, M.J.4
Seltzman, H.H.5
-
30
-
-
0033602129
-
Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
-
Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A: Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 1999;42:769-776.
-
(1999)
J Med Chem
, vol.42
, pp. 769-776
-
-
Lan, R.1
Liu, Q.2
Fan, P.3
Lin, S.4
Fernando, S.R.5
McCallion, D.6
Pertwee, R.7
Makriyannis, A.8
-
31
-
-
12744258029
-
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
-
Pertwee RG: Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci 2005;76:1307-1324.
-
(2005)
Life Sci
, vol.76
, pp. 1307-1324
-
-
Pertwee, R.G.1
-
33
-
-
4243447225
-
AM630 is an inverse agonist at the human cannabinoid CB1 receptor
-
Landsman RS, Makriyannis A, Deng H, Consroe P, Roeske WR, Yamamura HI: AM630 is an inverse agonist at the human cannabinoid CB1 receptor. Life Sci 1998;62:PL109-PL113.
-
(1998)
Life Sci
, vol.62
-
-
Landsman, R.S.1
Makriyannis, A.2
Deng, H.3
Consroe, P.4
Roeske, W.R.5
Yamamura, H.I.6
|